Clinical manifestations are complex and often involve multiple systemic manifestations. Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical manifestations, imaging examinations, laboratory tests and pathological biopsies.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune disorders that were previously difficult to treat have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes according to changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of neurological burden associated with Alzheimer's disease. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.